Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization.

Sprenkeler EGG, Henriet S, Tool A, Kreft IC, van der Bijl I, Aarts CCEM, van Houdt M, Verkuijlen P, van Aerde K, Jaspers G, van Heijst A, Koole W, Gardeitchik T, Geissler J, de Boer M, Tol S, Bruggeman CW, van Alphen F, Verhagen HJ, van den Akker E, Janssen H, van Bruggen R, van den Berg TK, Liem KD, Kuijpers TW.

Blood. 2020 Mar 3. pii: blood.2019002633. doi: 10.1182/blood.2019002633. [Epub ahead of print]

PMID:
32128589
2.

Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.

Temming AR, de Taeye SW, de Graaf EL, de Neef LA, Dekkers G, Bruggeman CW, Koers J, Ligthart P, Nagelkerke SQ, Zimring JC, Kuijpers TW, Wuhrer M, Rispens T, Vidarsson G.

J Immunol. 2019 Dec 15;203(12):3126-3135. doi: 10.4049/jimmunol.1900985. Epub 2019 Nov 20.

PMID:
31748349
3.

Tissue-specific expression of IgG receptors by human macrophages ex vivo.

Bruggeman CW, Houtzager J, Dierdorp B, Kers J, Pals ST, Lutter R, van Gulik T, den Haan JMM, van den Berg TK, van Bruggen R, Kuijpers TW.

PLoS One. 2019 Oct 15;14(10):e0223264. doi: 10.1371/journal.pone.0223264. eCollection 2019.

4.

FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.

Treffers LW, van Houdt M, Bruggeman CW, Heineke MH, Zhao XW, van der Heijden J, Nagelkerke SQ, Verkuijlen PJJH, Geissler J, Lissenberg-Thunnissen S, Valerius T, Peipp M, Franke K, van Bruggen R, Kuijpers TW, van Egmond M, Vidarsson G, Matlung HL, van den Berg TK.

Front Immunol. 2019 Jan 30;9:3124. doi: 10.3389/fimmu.2018.03124. eCollection 2018.

5.

Selective Serotonin Reuptake Inhibitor (SSRI) Toxicity.

Bruggeman C, O'Day CS.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.
2019 Dec 3.

6.

IgG Glyco-Engineering to Improve IVIg Potency.

Bruggeman CW, Dekkers G, Visser R, Goes NWM, van den Berg TK, Rispens T, Vidarsson G, Kuijpers TW.

Front Immunol. 2018 Oct 23;9:2442. doi: 10.3389/fimmu.2018.02442. eCollection 2018.

7.

Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors.

Nagelkerke SQ, Bruggeman CW, den Haan JMM, Mul EPJ, van den Berg TK, van Bruggen R, Kuijpers TW.

Blood Adv. 2018 Apr 24;2(8):941-953. doi: 10.1182/bloodadvances.2017015008.

8.

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.

Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J.

Blood. 2018 Feb 15;131(7):830-835. doi: 10.1182/blood-2017-07-796151. Epub 2018 Jan 5. No abstract available.

PMID:
29305554
9.

Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease.

Meinderts SM, Sins JWR, Fijnvandraat K, Nagelkerke SQ, Geissler J, Tanck MW, Bruggeman C, Biemond BJ, Rijneveld AW, Kerkhoffs JH, Pakdaman S, Habibi A, van Bruggen R, Kuijpers TW, Pirenne F, van den Berg TK.

Blood. 2017 Nov 9;130(19):2121-2130. doi: 10.1182/blood-2017-05-784876. Epub 2017 Sep 12.

PMID:
28899854
10.

Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.

Bruggeman CW, Dekkers G, Bentlage AEH, Treffers LW, Nagelkerke SQ, Lissenberg-Thunnissen S, Koeleman CAM, Wuhrer M, van den Berg TK, Rispens T, Vidarsson G, Kuijpers TW.

J Immunol. 2017 Jul 1;199(1):204-211. doi: 10.4049/jimmunol.1700116. Epub 2017 May 31.

11.

Effector Regulatory T Cell Differentiation and Immune Homeostasis Depend on the Transcription Factor Myb.

Dias S, D'Amico A, Cretney E, Liao Y, Tellier J, Bruggeman C, Almeida FF, Leahy J, Belz GT, Smyth GK, Shi W, Nutt SL.

Immunity. 2017 Jan 17;46(1):78-91. doi: 10.1016/j.immuni.2016.12.017.

12.

Prevalence and antibiotic resistance of commensal Streptococcus pneumoniae in nine European countries.

Yahiaoui RY, den Heijer CDj, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA, Schellevis FG, Stobberingh EE; APRES Study Team.

Future Microbiol. 2016 Jun;11:737-44. doi: 10.2217/fmb-2015-0011. Epub 2016 May 18.

PMID:
27191588
13.

Comparison of urine samples and penile swabs for detection of human papillomavirus in HIV-negative Dutch men.

Koene F, Wolffs P, Brink A, Dukers-Muijrers N, Quint W, Bruggeman C, Hoebe C.

Sex Transm Infect. 2016 Sep;92(6):467-9. doi: 10.1136/sextrans-2015-052054. Epub 2016 Feb 26.

PMID:
26920866
14.

Alteration of the molecular-size-distribution of Boom Clay dissolved organic matter induced by Na(+) and Ca(2).

Durce D, Maes N, Bruggeman C, Van Ravestyn L.

J Contam Hydrol. 2016 Feb-Mar;185-186:14-27. doi: 10.1016/j.jconhyd.2015.12.001. Epub 2015 Dec 19.

PMID:
26788872
15.

Evaluation of phenotypic and molecular methods for identification of Streptococcus pneumoniae.

Yahiaoui RY, den Heijer CD, Wolfs P, Bruggeman CA, Stobberingh EE.

Future Microbiol. 2016;11(1):43-50. doi: 10.2217/fmb.15.124. Epub 2015 Dec 17.

PMID:
26673889
16.

Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.

Haeseker M, Croes S, Neef C, Bruggeman C, Stolk L, Verbon A.

Ther Drug Monit. 2016 Feb;38(1):120-6. doi: 10.1097/FTD.0000000000000250.

PMID:
26418699
17.

Assessment of co-contaminant effects on uranium and thorium speciation in freshwater using geochemical modelling.

Lofts S, Fevrier L, Horemans N, Gilbin R, Bruggeman C, Vandenhove H.

J Environ Radioact. 2015 Nov;149:99-109. doi: 10.1016/j.jenvrad.2015.07.011. Epub 2015 Jul 28.

PMID:
26225834
18.

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, Miller ML, Rekhtman N, Moreira AL, Ibrahim F, Bruggeman C, Gasmi B, Zappasodi R, Maeda Y, Sander C, Garon EB, Merghoub T, Wolchok JD, Schumacher TN, Chan TA.

Science. 2015 Apr 3;348(6230):124-8. doi: 10.1126/science.aaa1348. Epub 2015 Mar 12.

19.

Confirmation of high specificity of an automated enzyme immunoassay test for serological diagnosis of syphilis: retrospective evaluation versus results after implementation.

van Dommelen L, Hoebe CJ, van Tiel FH, Thijs C, Goossens VJ, Bruggeman CA, van Loo IH.

Sex Transm Dis. 2015 Mar;42(3):120-2. doi: 10.1097/OLQ.0000000000000240.

PMID:
25668642
20.

Impact of same-day antibiotic susceptibility testing on time to appropriate antibiotic treatment of patients with bacteraemia: a randomised controlled trial.

Beuving J, Wolffs PF, Hansen WL, Stobberingh EE, Bruggeman CA, Kessels A, Verbon A.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):831-8. doi: 10.1007/s10096-014-2299-0. Epub 2014 Dec 20.

PMID:
25527447
21.

Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community.

van Bijnen EM, Paget WJ, den Heijer CD, Stobberingh EE, Bruggeman CA, Schellevis FG; APRES Study Team.

BMC Fam Pract. 2014 Oct 25;15:175. doi: 10.1186/s12875-014-0175-8.

22.

Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections.

Gulraiz F, Bellinghausen C, Bruggeman CA, Stassen FR.

FASEB J. 2015 Mar;29(3):849-58. doi: 10.1096/fj.14-254359. Epub 2014 Nov 19.

PMID:
25411435
23.

Genetic basis for clinical response to CTLA-4 blockade in melanoma.

Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, Walsh LA, Postow MA, Wong P, Ho TS, Hollmann TJ, Bruggeman C, Kannan K, Li Y, Elipenahli C, Liu C, Harbison CT, Wang L, Ribas A, Wolchok JD, Chan TA.

N Engl J Med. 2014 Dec 4;371(23):2189-2199. doi: 10.1056/NEJMoa1406498. Epub 2014 Nov 19. Erratum in: N Engl J Med. 2018 Nov 29;379(22):2185.

24.

Vancomycin dosing in neutropenic patients.

Haeseker MB, Croes S, Neef C, Bruggeman CA, Stolk LM, Verbon A.

PLoS One. 2014 Nov 12;9(11):e112008. doi: 10.1371/journal.pone.0112008. eCollection 2014.

25.

Comparison of three different techniques for the isolation of viral RNA in sputum.

Vanspauwen MJ, Wolffs PF, Franssen FM, Bruggeman CA, Wouters EF, Linssen CF.

J Clin Virol. 2014 Oct;61(2):265-9. doi: 10.1016/j.jcv.2014.07.012. Epub 2014 Jul 28.

PMID:
25132398
26.

Molecular epidemiology of Pneumocystis jiroveci in human immunodeficiency virus-positive and -negative immunocompromised patients in The Netherlands.

Vanspauwen MJ, Knops VEJ, Bruggeman CA, van Mook WNKA, Linssen CFM.

J Med Microbiol. 2014 Oct;63(Pt 10):1294-1302. doi: 10.1099/jmm.0.076257-0. Epub 2014 Jul 24.

PMID:
25060971
27.

Is the standard dose of amoxicillin-clavulanic acid sufficient?

Haeseker M, Havenith T, Stolk L, Neef C, Bruggeman C, Verbon A.

BMC Pharmacol Toxicol. 2014 Jul 21;15:38. doi: 10.1186/2050-6511-15-38.

28.

Developments for improved diagnosis of bacterial bloodstream infections.

Loonen AJ, Wolffs PF, Bruggeman CA, van den Brule AJ.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1687-702. doi: 10.1007/s10096-014-2153-4. Epub 2014 May 22. Review.

PMID:
24848132
29.

Microbiology of surgical site infections after gastrointestinal surgery in the south region of The Netherlands.

Ramcharan AA, den Heijer CD, Smeets EE, Rouflart MM, van Tiel FH, Bruggeman CA, Breukink SO, Tordoir JH, Baeten CG, Stobberingh EE.

Future Microbiol. 2014;9(3):291-8. doi: 10.2217/fmb.13.169.

PMID:
24762304
30.

Efficacy of IFN-λ1 to protect human airway epithelial cells against human rhinovirus 1B infection.

Gulraiz F, Bellinghausen C, Dentener MA, Reynaert NL, Gaajetaan GR, Beuken EV, Rohde GG, Bruggeman CA, Stassen FR.

PLoS One. 2014 Apr 21;9(4):e95134. doi: 10.1371/journal.pone.0095134. eCollection 2014.

31.

Evidence-based primary care treatment guidelines for skin infections in Europe: a comparative analysis.

van Bijnen EM, Paget J, den Heijer CD, Stobberingh EE, Bruggeman CA, Schellevis FG; APRES study team.

Eur J Gen Pract. 2014 Dec;20(4):294-300. doi: 10.3109/13814788.2013.872621. Epub 2014 Jan 23.

PMID:
24456348
32.

Cross-sectional study on surveillance of surgical site infections after vascular surgery.

Ramcharan A, Penders J, Smeets E, Rouflart M, Tiel Fv, Bruggeman C, Baeten C, Breukink S, Tordoir J, Stobberingh E.

Future Microbiol. 2013 Nov;8(11):1373-80. doi: 10.2217/fmb.13.112.

PMID:
24199797
33.

The host immune response contributes to Haemophilus influenzae virulence.

Geelen TH, Gaajetaan GR, Wouters EF, Rohde GG, Franssen FM, Grauls GE, Stobberingh EE, Bruggeman CA, Stassen FR.

Respir Med. 2014 Jan;108(1):144-52. doi: 10.1016/j.rmed.2013.08.005. Epub 2013 Sep 5.

34.

Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study.

Haeseker MB, Pijpers E, Dukers-Muijrers NH, Nelemans P, Hoebe CJ, Bruggeman CA, Verbon A, Goossens VJ.

Immun Ageing. 2013 Jul 23;10(1):30. doi: 10.1186/1742-4933-10-30.

35.

Mimivirus is not a frequent cause of ventilator-associated pneumonia in critically ill patients.

Vanspauwen MJ, Schnabel RM, Bruggeman CA, Drent M, van Mook WN, Bergmans DC, Linssen CF.

J Med Virol. 2013 Oct;85(10):1836-41. doi: 10.1002/jmv.23655. Epub 2013 Jul 16.

PMID:
23861144
36.

Antimicrobial resistance among respiratory Haemophilus influenzae isolates from pulmonology services over a six-year period.

Geelen TH, Stassen FR, Hoogkamp-Korstanje JA, Bruggeman CA, Stobberingh EE; Antimicrobial Resistance Surveillance Group.

Scand J Infect Dis. 2013 Aug;45(8):606-11. doi: 10.3109/00365548.2013.796088. Epub 2013 Jun 9.

PMID:
23746341
37.

A real-time PCR-based semi-quantitative breakpoint to aid in molecular identification of urinary tract infections.

Hansen WL, van der Donk CF, Bruggeman CA, Stobberingh EE, Wolffs PF.

PLoS One. 2013 Apr 23;8(4):e61439. doi: 10.1371/journal.pone.0061439. Print 2013.

38.

The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study.

den Heijer CD, Penders J, Donker GA, Bruggeman CA, Stobberingh EE.

PLoS One. 2013;8(3):e60497. doi: 10.1371/journal.pone.0060497. Epub 2013 Mar 29.

39.

Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study.

den Heijer CD, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA, Schellevis FG, Stobberingh EE; APRES Study Team.

Lancet Infect Dis. 2013 May;13(5):409-15. doi: 10.1016/S1473-3099(13)70036-7. Epub 2013 Mar 6. Erratum in: Lancet Infect Dis. 2013 Dec;13(12):1011. Flemming, Douglas [corrected to Fleming, Douglas].

PMID:
23473661
40.

Improving sexual health for HIV patients by providing a combination of integrated public health and hospital care services; a one-group pre- and post test intervention comparison.

Dukers-Muijrers NH, Somers C, Hoebe CJ, Lowe SH, Niekamp AM, Oude Lashof A, Bruggeman CA, Vrijhoef HJ.

BMC Public Health. 2012 Dec 27;12:1118. doi: 10.1186/1471-2458-12-1118.

41.

Oral and topical antibiotic prescriptions for children in general practice.

de Bont EG, van Loo IH, Dukers-Muijrers NH, Hoebe CJ, Bruggeman CA, Dinant GJ, Cals JW.

Arch Dis Child. 2013 Mar;98(3):228-31. doi: 10.1136/archdischild-2012-303134. Epub 2012 Dec 25.

PMID:
23268371
42.

Influence of temperature, medium, and storage duration on Chlamydia trachomatis DNA detection by PCR.

van Dommelen L, Wolffs PF, van Tiel FH, Dukers N, Herngreen SB, Bruggeman CA, Hoebe CJ.

J Clin Microbiol. 2013 Mar;51(3):990-2. doi: 10.1128/JCM.02631-12. Epub 2012 Dec 19.

43.

Trends in antibiotic prescribing in adults in Dutch general practice.

Haeseker MB, Dukers-Muijrers NH, Hoebe CJ, Bruggeman CA, Cals JW, Verbon A.

PLoS One. 2012;7(12):e51860. doi: 10.1371/journal.pone.0051860. Epub 2012 Dec 12.

44.

Interferon-β induces a long-lasting antiviral state in human respiratory epithelial cells.

Gaajetaan GR, Geelen TH, Vernooy JH, Dentener MA, Reynaert NL, Rohde GG, Beuken EV, Grauls GE, Bruggeman CA, Stassen FR.

J Infect. 2013 Feb;66(2):163-9. doi: 10.1016/j.jinf.2012.11.008. Epub 2012 Nov 28.

PMID:
23201152
45.

Pre-analytical sample treatment and DNA extraction protocols for the detection of bacterial pathogens from whole blood.

Hansen WL, Bruggeman CA, Wolffs PF.

Methods Mol Biol. 2013;943:81-90. doi: 10.1007/978-1-60327-353-4_4.

PMID:
23104282
46.

Infections with mimivirus in patients with chronic obstructive pulmonary disease.

Vanspauwen MJ, Franssen FM, Raoult D, Wouters EF, Bruggeman CA, Linssen CF.

Respir Med. 2012 Dec;106(12):1690-4. doi: 10.1016/j.rmed.2012.08.019. Epub 2012 Sep 16.

47.

Impact of bacterial colonization on exhaled inflammatory markers in wheezing preschool children.

van de Kant KD, Klaassen EM, van Aerde KJ, Damoiseaux J, Bruggeman CA, Stelma FF, Stobberingh EE, Muris JW, Jöbsis Q, van Schayck OC, Dompeling E.

J Breath Res. 2012 Dec;6(4):046001. doi: 10.1088/1752-7155/6/4/046001. Epub 2012 Sep 18. Erratum in: J Breath Res. 2012 Dec;6(4):049601.

PMID:
22990010
48.

Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region.

Hackert VH, van der Hoek W, Dukers-Muijrers N, de Bruin A, Al Dahouk S, Neubauer H, Bruggeman CA, Hoebe CJ.

Clin Infect Dis. 2012 Dec;55(12):1591-9. doi: 10.1093/cid/cis734. Epub 2012 Aug 23.

PMID:
22918992
49.

Antimicrobial resistance and molecular typing of Staphylococcus aureus bloodstream isolates from hospitals in Peru.

García C, Rijnders MI, Bruggeman C, Samalvides F, Stobberingh EE, Jacobs J.

J Infect. 2012 Nov;65(5):406-11. doi: 10.1016/j.jinf.2012.06.009. Epub 2012 Jun 28.

PMID:
22750236
50.

Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseases.

Dennert R, van Paassen P, Wolffs P, Bruggeman C, Velthuis S, Felix S, van Suylen RJ, Crijns HJ, Cohen Tervaert JW, Heymans S.

Clin Vaccine Immunol. 2012 Aug;19(8):1182-7. doi: 10.1128/CVI.00281-12. Epub 2012 Jun 13.

Supplemental Content

Loading ...
Support Center